Cargando…
Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation
BACKGROUND AND OBJECTIVES: Antibodies (Abs) against the cytoplasmic protein glutamic acid decarboxylase 65 (GAD65) are detected in patients with neurologic syndromes together referred to as GAD65-Ab spectrum disorders. The response of some of these patients to plasma exchange or immunoglobulins indi...
Autores principales: | Biljecki, Michelle, Eisenhut, Katharina, Beltrán, Eduardo, Winklmeier, Stephan, Mader, Simone, Thaller, Anna, Eichhorn, Peter, Steininger, Philipp, Flierl-Hecht, Andrea, Lewerenz, Jan, Kümpfel, Tania, Kerschensteiner, Martin, Meinl, Edgar, Thaler, Franziska S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969496/ https://www.ncbi.nlm.nih.gov/pubmed/36823135 http://dx.doi.org/10.1212/NXI.0000000000200090 |
Ejemplares similares
-
Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017) -
Epilepsy in patients with insulin-dependent diabetes and relation to glutamic acid decarboxylase 65
por: Mahmoud, Adel A., et al.
Publicado: (2020) -
Hypercapnic ventilatory response in mice lacking the 65 kDa isoform of Glutamic Acid Decarboxylase (GAD65)
por: Bissonnette, John M, et al.
Publicado: (2004) -
Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012) -
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
por: Schlüter, Miriam, et al.
Publicado: (2021)